Association of CTLA-4 (AT)n Variants in Basal Cell Carcinoma and Squamous Cell Carcinoma Patients from Western Mexico
Open Access
- 1 August 2024
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (8) , 8368-8375
Abstract
The incidence of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) is constantly increasing, becoming a significant health problem. CTLA-4 is a critical immune checkpoint, and it has been suggested that a variant of variable-number tandem repeat in the 3’-UTR of its gene, known as (AT)n, may be associated with a higher susceptibility to some cancers; however, little is known about genetic variants of the CTLA-4 gene in NMSC. To establish the association of this genetic variant in the CTLA-4 gene with the susceptibility of NMSC carcinogenesis in the Western Mexican population, samples from 150 BCC patients, 150 SCC patients, and 150 healthy individuals as the reference group (RG) were analyzed by endpoint PCR, followed by electrophoresis to genotype the samples. We found that the short-repeat 104/104 bp genotype may be a risk factor for BBC carcinogens (OR = 2.92, p = 0.03), whereas the long-repeat 106/106 bp genotype may be a protective factor for both BCC (OR = 0.13, p = 0.01) and SCC (OR = 0.32, p = 0.01) susceptibility. Our results show that in the Western Mexican population, long-repeat (AT)n variants in the CTLA-4 gene are associated with a protective factor in BCC and SCC. In contrast, short repeats are associated with a risk factor.Keywords
Funding Information
- University of Guadalajara (PROSNI-CUCS-UDG-2023)
This publication has 38 references indexed in Scilit:
- Haplotypes of [‐794(CATT)5–8/‐173G>C] MIF gene polymorphisms and its soluble levels in cutaneous squamous cell carcinoma in western Mexican populationMolecular Genetics & Genomic Medicine, 2023
- Immunotherapy for Non-melanoma Skin CancerCurrent Oncology Reports, 2021
- Molecular and Cellular Functions of CTLA-42020
- Combined evaluation of the expression status of CD155 and TIGIT plays an important role in the prognosis of LUAD (lung adenocarcinoma)International Immunopharmacology, 2020
- Non-Melanoma Skin Cancers in the Older PatientCurrent Oncology Reports, 2019
- Is the Genetic Background of Co-Stimulatory CD28/CTLA-4 Pathway the Risk Factor for Prostate Cancer?Pathology and Oncology Research, 2017
- CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancerHuman Immunology, 2011
- Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish populationHuman Immunology, 2010
- Non-melanoma skin cancer: Importance of gender, immunosuppressive status and vitamin DCancer Letters, 2008
- The 3′ UTR of the human CTLA4 mRNA can regulate mRNA stability and translational efficiencyBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2008